Agostinetto E, Buisseret L, Salgado R, Kok M, et al. Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: Does it help tailor adjuvant treatment? Ann Oncol 2024 Mar 12:S0923-7534(24)00077-2. doi: 10.1016/j.annonc.2024.
PMID: 38484973